cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Mannkind Corp
28 own
46 watching
Current Price
$4.06
$-0.05
(-1.22%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,074.35M
52-Week High
52-Week High
5.75000
52-Week Low
52-Week Low
2.91000
Average Volume
Average Volume
1.92M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,074.35M
icon52-Week High5.75000
icon52-Week Low2.91000
iconAverage Volume1.92M
iconDividend Yield--
iconP/E Ratio--
What does the Mannkind Corp do?
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes diseases in the United States. Its approved product is Afrezza, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. The company was founded in 1991 and is based in Valencia, California.
Read More
How much money does Mannkind Corp make?
News & Events about Mannkind Corp.
Globe Newswire
3 months ago
DANBURY, Conn., June 11, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will host Connecticut Governor Ned Lamont for a tour of its headquarters on Monday, June 12. The visit coincides with MannKind reaching a manufacturing milestone as it has successfully scaled-up operations for ...
PR Newswire
7 months ago
Thinking about buying stock in Timber Pharmaceuticals, Warner Bros, Alibaba, MannKind, or ON Semiconductor? Thinking about buying stock in Timber Pharmaceuticals, Warner Bros, Alibaba, MannKind, or ON Semiconductor? PR Newswire NEW YORK, Feb. 24, 2023 NEW YORK, Feb. 24, 2023 /PRNewswire...
Globe Newswire
10 months ago
Conference Call to Begin Today at 9:00 a.m. (ET)3Q 2022 Total Revenues of $32.8 million; +48% vs. 3Q 20213Q 2022 Royalties from Tyvaso DPI of $6.2 million3Q 2022 Commercial Products Net Revenue of $16.3 million; +67% vs. 3Q 2021 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 08, 2022 (GLOBE ...
Simply Wall St
1 year ago
A look at the shareholders of MannKind Corporation ( NASDAQ:MNKD ) can tell us which group is most powerful. And the...
Frequently Asked Questions
Frequently Asked Questions
What is Mannkind Corp share price today?
plus_minus_icon
Can Indians buy Mannkind Corp shares?
plus_minus_icon
How can I buy Mannkind Corp shares from India?
plus_minus_icon
Can Fractional shares of Mannkind Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Mannkind Corp stocks?
plus_minus_icon
What is today’s traded volume of Mannkind Corp?
plus_minus_icon
What is today’s market capitalisation of Mannkind Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Mannkind Corp?
plus_minus_icon
What percentage is Mannkind Corp down from its 52-Week High?
plus_minus_icon
What percentage is Mannkind Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$4.06
$-0.05
(-1.22%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc
$0.78
$0.01 (1.89 %)
Cymabay Therapeutics Inc
Cymabay Therapeutics Inc
$14.71
$0.11 (0.75 %)
MARINUS PHARMACEUTICALS INC
MARINUS PHARMACEUTICALS INC
$6.60
$-0.15 (-2.22 %)
Ascendis Pharma A/S
Ascendis Pharma A/S
$95.06
$-0.38 (-0.40 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc
$0.78
$0.01 (1.89 %)
Cymabay Therapeutics Inc
Cymabay Therapeutics Inc
$14.71
$0.11 (0.75 %)
MARINUS PHARMACEUTICALS INC
MARINUS PHARMACEUTICALS INC
$6.60
$-0.15 (-2.22 %)
Ascendis Pharma A/S
Ascendis Pharma A/S
$95.06
$-0.38 (-0.40 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00